Lindsay Claxton

8PUBLICATIONS
48CO-AUTHORS
Molecular targetsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 05, 2026
Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic model.

|Jan 25, 2022
Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation.

Lindsay Claxton, Mark Simmonds, Lucy Beresford

|Jan 06, 2022
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.

Peter Murphy, David Glynn, Sofia Dias

|Oct 01, 2020
Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.

Matthew Walton, Ros Wade, Lindsay Claxton

|Apr 16, 2019
Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan.

Der-Yuan Chen, Ping-Ning Hsu, Chao-Hsiun Tang

|Nov 23, 2018
Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.

Lindsay Claxton, Joanne O'Connor, Nerys Woolacott

Pageof 2

Frequent Collaborators

2 joint publications

Sahar Sharif-Hurst

2 joint publications

Robert Hodgson

2 joint publications

Kath Wright

2 joint publications

Lucy Beresford